+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bird Flu Treatment Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Bird Flu Treatment Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Bird Flu Treatment Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6010916
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bird Flu Treatment Market grew from USD 23.85 billion in 2024 to USD 25.86 billion in 2025. It is expected to continue growing at a CAGR of 8.21%, reaching USD 38.30 billion by 2030.

The global struggle against avian influenza has intensified in recent years as novel outbreaks challenge public health infrastructures and therapeutic capabilities. Bird flu, caused by multiple influenza A virus subtypes, poses significant zoonotic risk and demands a coordinated medical and scientific response. The evolving nature of virus strains, increased diversity of treatment modalities, and shifting regulatory environments underscore the critical importance of a comprehensive overview. This introduction establishes the foundational context for understanding how technological breakthroughs, policy changes, and market drivers converge to shape current patient care pathways and future strategies for bird flu management.

Transformative Shifts Shaping the Bird Flu Treatment Landscape

Bird flu treatment has experienced several transformative shifts in recent years. First, the emergence of new virus subtypes such as H5N6 and H7N9 has prompted a reevaluation of existing therapeutic arsenals. In response, drug developers have accelerated research in advanced antiviral compounds, leveraging molecular assays and high-throughput screening to identify agents with broad-spectrum activity. Meanwhile, vaccine platforms have evolved from traditional egg-based production to recombinant and vector-based technologies, enhancing both speed and scalability.

Regulatory bodies are also redefining approval pathways through adaptive licensing frameworks that allow conditional authorizations during public health emergencies. Public-private partnerships have expanded clinical trial networks, enabling more robust data collection across geographies. In parallel, digital health solutions for remote patient monitoring and telemedicine have improved outpatient management, reducing hospital burden. As such, stakeholders must navigate a landscape where scientific innovation, policy reform, and digital transformation intersect to deliver more effective bird flu treatments.

Cumulative Impact of United States Tariffs in 2025 on Treatment Supply Chains

United States tariffs introduced in early 2025 have reshaped the economics of antiviral drug manufacturing and distribution. Increased duties on imported raw materials, including key active pharmaceutical ingredients and specialty reagents, have driven up production costs for manufacturers reliant on global supply chains. Consequently, major vaccine producers faced higher overhead for recombinant vector components sourced from overseas facilities.

Moreover, tariffs on laboratory equipment and single-use bioreactors have forced some research organizations to invest in domestic production capabilities, thereby delaying certain development timelines. Hospitals and public health clinics have adjusted procurement strategies by securing local suppliers for personal protective equipment and diagnostic kits to mitigate cost volatility. In turn, pharmaceutical companies and distributors have implemented dynamic pricing models and sought longer-term contracts to stabilize revenue streams. Overall, these tariff measures have catalyzed greater domestic capacity building while introducing new financial pressures across the bird flu treatment ecosystem.

Key Segmentation Insights into Virus Strains, Treatments, and End Users

A detailed segmentation analysis reveals nuanced opportunities and challenges across distinct categories. Based on virus strains, the market must address high-pathogenic subtypes such as H5N1, H5N6, H5N8, H7N9, and H9N2, each with unique mutation profiles that affect transmissibility and virulence. Treatment type segmentation highlights traditional antiviral drugs subdivided into adamantanes, favipiravir, and neuraminidase inhibitors alongside emerging modalities including convalescent plasma therapy, immunomodulators like interferons and monoclonal antibodies, supportive care components such as hydration solutions and oxygen therapy, and a spectrum of traditional and herbal remedies. Vaccine development has diversified into inactivated vaccines, live attenuated formulations, and advanced recombinant options classified by protein-based and vector-based platforms.

Patient demographics segmentation underscores varied therapeutic needs across adult, geriatric, pediatric, and pregnant women populations, each requiring tailored dosing regimens and safety considerations. Disease severity analysis distinguishes mild, moderate, and severe cases to inform resource allocation from outpatient clinics to intensive care units. End user segmentation extends to ambulatory care centers, hospitals and clinics, pharmaceutical companies, and research organizations, reflecting how treatment pathways and procurement differ by setting.

Distribution channel segmentation covers hospital pharmacies, online pharmacies, public health clinics, and retail pharmacies, illustrating the importance of multi-channel strategies for equitable access. Mode of administration ranges from inhalational delivery to intramuscular, intravenous, and oral routes, each impacting patient compliance and logistical planning. Preventive measures segmentation includes personal protective equipment such as gloves and masks, public health initiatives, and widespread vaccination programs aimed at reducing transmission. Research and innovation efforts focus on advanced antiviral research, new vaccine platforms, and novel drug formulations, driving the frontier of therapeutic efficacy. Industry stakeholders such as government agencies, healthcare providers, and vaccine manufacturers play pivotal roles in policy setting, clinical implementation, and production scale-up. Finally, socio-economic impact assessment emphasizes the interplay between healthcare costs and public awareness campaigns in shaping vaccine uptake and funding priorities.

Key Regional Insights across Americas, EMEA, and Asia-Pacific

Regional dynamics significantly influence bird flu treatment strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established pharmaceutical infrastructure and robust R&D ecosystems have enabled rapid scale-up of antiviral production and vaccine trials. North American public health agencies have prioritized stockpiling key therapeutics, while Latin American countries are strengthening distribution networks through partnerships with local manufacturers.

Meanwhile, Europe, the Middle East & Africa have leveraged collaborative frameworks under regional bodies to harmonize regulatory requirements. European Union initiatives support cross-border clinical studies, and several Middle Eastern nations are increasing investments in biomanufacturing hubs. Within Africa, capacity-building programs focus on community health outreach and improving cold chain logistics for vaccines.

In the Asia-Pacific region, high incidence of avian influenza outbreaks has accelerated innovation among biotech firms and government-led research institutions. Countries such as China and India have become key vaccine exporters, while Southeast Asian public health campaigns emphasize integrated surveillance and early treatment protocols. Overall, each region’s mix of regulatory environment, manufacturing capacity, and healthcare infrastructure shapes the deployment and uptake of bird flu therapeutics.

Key Company Insights Driving Innovation and Market Dynamics

A diverse group of industry participants is driving both incremental and disruptive advancements in bird flu treatment. Alltech, Inc. and Ceva Santé Animale are leveraging expertise in animal health to develop vaccines that mitigate zoonotic spillover. BioCryst Pharmaceuticals, Inc. and Gilead Sciences, Inc. focus on small-molecule antivirals, optimizing potency against neuraminidase targets. Boehringer Ingelheim International GmbH and F. Hoffmann-La Roche Ltd. integrate biologic platforms, advancing monoclonal antibodies and interferon-based immunotherapies. Cipla Limited and Macleods Pharmaceuticals Ltd. specialize in cost-effective generic antivirals and supportive care formulations for emerging markets.

CSL Limited and Serum Institute of India Pvt. Ltd. have scaled up production of traditional inactivated vaccines, while Moderna, Inc. and Novartis AG invest heavily in novel mRNA and recombinant vector-based platforms. Pfizer Inc. and Sanofi S.A. maintain broad vaccine portfolios, spanning egg-based, live attenuated, and protein subunit technologies. Merck KGaA and Takeda Pharmaceutical Company Limited emphasize integrated R&D pipelines that include advanced antiviral research and novel drug formulations. Sinovac Biotech Ltd. and Yebio Bioengineering Co. Ltd. capitalize on regional manufacturing to meet domestic and export demand, whereas Hester Biosciences Limited focuses on veterinary vaccines to curb livestock reservoirs. Johnson & Johnson Services, Inc. and Zoetis Inc. introduce cross-sector collaborations, aligning human and animal health initiatives.

FATRO S.p.A. and Tianjin Ringpu Biotechnology Co. Ltd. refine adjuvant systems to boost immunogenicity, and PetSmart LLC channels consumer awareness through preventive measures like personal protective equipment, reinforcing market education. Together, these companies encompass the full spectrum of therapeutic intervention, from upstream R&D to downstream distribution and community engagement.

Actionable Recommendations for Industry Leaders

Industry leaders should consider a multi-pronged strategy to strengthen bird flu treatment readiness. First, accelerate investment in next-generation vaccine platforms, particularly recombinant and mRNA technologies, to shorten development cycles and enhance strain coverage. In addition, establish strategic partnerships with domestic API suppliers and equipment manufacturers to mitigate tariff-induced supply chain disruptions.

Second, expand digital health integration by deploying telemedicine solutions for early diagnosis and remote patient management, thereby reducing hospitalization rates and optimizing resource utilization. Concurrently, forge alliances between government agencies, healthcare providers, and vaccine manufacturers to streamline regulatory approvals and share real-world data.

Third, bolster local manufacturing capabilities in underserved regions through technology transfer agreements and capacity-building initiatives. This will improve equitable access to antivirals and vaccines while lowering logistical barriers. Finally, prioritize public awareness campaigns that connect healthcare costs with community-level prevention measures, reinforcing the importance of vaccination programs and personal protective equipment.

Conclusion: Strategic Imperatives for Future Preparedness

The evolving bird flu treatment landscape demands strategic foresight and collaborative execution. Continued innovation across antivirals, immunotherapies, and vaccines is essential to counter emerging virus strains. Simultaneously, adaptive regulatory frameworks and resilient supply chains must align to sustain rapid scale-up during outbreaks. Cross-sector partnerships among public health institutions, private industry, and research organizations will underpin more agile responses and efficient resource allocation.

By leveraging advanced R&D, strengthening regional manufacturing, and integrating digital health solutions, stakeholders can enhance patient outcomes and mitigate economic disruptions. Ultimately, a unified approach that balances scientific rigor with operational adaptability will chart the path toward more effective bird flu prevention and treatment globally.

Market Segmentation & Coverage

This research report categorizes the Bird Flu Treatment Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • H5N1
  • H5N6
  • H5N8
  • H7N9
  • H9N2
  • Antiviral Drugs
    • Adamantanes
    • Favipiravir
    • Neuraminidase Inhibitors
  • Convalescent Plasma Therapy
  • Immunomodulators
    • Interferons
    • Monoclonal Antibodies
  • Supportive Care
    • Hydration Solutions
    • Oxygen Therapy
  • Traditional and Herbal Remedies
  • Vaccines
    • Inactivated Vaccines
    • Live Attenuated Vaccines
    • Recombinant Vaccines
      • Protein-based
      • Vector-based
  • Adult
  • Geriatric
  • Pediatric
  • Pregnant Women
  • Mild Cases
  • Moderate Cases
  • Severe Cases
  • Ambulatory Care Centers
  • Hospitals and Clinics
  • Pharmaceutical Companies
  • Research Organizations
  • Hospital Pharmacies
  • Online Pharmacies
  • Public Health Clinics
  • Retail Pharmacies
  • Inhalational
  • Intramuscular
  • Intravenous
  • Oral
  • Personal Protective Equipment
    • Gloves
    • Masks
  • Public Health Initiatives
  • Vaccination Programs
  • Advanced Antiviral Research
  • New Vaccine Platforms
  • Novel Drug Formulations
  • Government Agencies
  • Healthcare Providers
  • Vaccine Manufacturers
  • Healthcare Costs
  • Public Awareness Campaigns

This research report categorizes the Bird Flu Treatment Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Bird Flu Treatment Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Alltech, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Cipla Limited
  • CSL Limited
  • F. Hoffmann-La Roche Ltd.
  • FATRO S.p.A.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Hester Biosciences Limited
  • Johnson & Johnson Services, Inc.
  • Macleods Pharmaceuticals Ltd
  • Merck KGaA
  • Moderna, Inc.
  • Novartis AG
  • PetSmart LLC
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Tianjin Ringpu Biotechnology Co. Ltd.
  • Yebio Bioengineering Co. Ltd.
  • Zoetis Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bird Flu Treatment Market, by Virus Strains
8.1. Introduction
8.2. H5N1
8.3. H5N6
8.4. H5N8
8.5. H7N9
8.6. H9N2
9. Bird Flu Treatment Market, by Treatment Type
9.1. Introduction
9.2. Antiviral Drugs
9.2.1. Adamantanes
9.2.2. Favipiravir
9.2.3. Neuraminidase Inhibitors
9.3. Convalescent Plasma Therapy
9.4. Immunomodulators
9.4.1. Interferons
9.4.2. Monoclonal Antibodies
9.5. Supportive Care
9.5.1. Hydration Solutions
9.5.2. Oxygen Therapy
9.6. Traditional and Herbal Remedies
9.7. Vaccines
9.7.1. Inactivated Vaccines
9.7.2. Live Attenuated Vaccines
9.7.3. Recombinant Vaccines
9.7.3.1. Protein-based
9.7.3.2. Vector-based
10. Bird Flu Treatment Market, by Patient Demographics
10.1. Introduction
10.2. Adult
10.3. Geriatric
10.4. Pediatric
10.5. Pregnant Women
11. Bird Flu Treatment Market, by Disease Severity
11.1. Introduction
11.2. Mild Cases
11.3. Moderate Cases
11.4. Severe Cases
12. Bird Flu Treatment Market, by End Users
12.1. Introduction
12.2. Ambulatory Care Centers
12.3. Hospitals and Clinics
12.4. Pharmaceutical Companies
12.5. Research Organizations
13. Bird Flu Treatment Market, by Distribution Channels
13.1. Introduction
13.2. Hospital Pharmacies
13.3. Online Pharmacies
13.4. Public Health Clinics
13.5. Retail Pharmacies
14. Bird Flu Treatment Market, by Mode of Administration
14.1. Introduction
14.2. Inhalational
14.3. Intramuscular
14.4. Intravenous
14.5. Oral
15. Bird Flu Treatment Market, by Preventive Measures
15.1. Introduction
15.2. Personal Protective Equipment
15.2.1. Gloves
15.2.2. Masks
15.3. Public Health Initiatives
15.4. Vaccination Programs
16. Bird Flu Treatment Market, by R&D and Innovation
16.1. Introduction
16.2. Advanced Antiviral Research
16.3. New Vaccine Platforms
16.4. Novel Drug Formulations
17. Bird Flu Treatment Market, by Industry Stakeholders
17.1. Introduction
17.2. Government Agencies
17.3. Healthcare Providers
17.4. Vaccine Manufacturers
18. Bird Flu Treatment Market, by Socio-Economic Impact
18.1. Introduction
18.2. Healthcare Costs
18.3. Public Awareness Campaigns
19. Americas Bird Flu Treatment Market
19.1. Introduction
19.2. Argentina
19.3. Brazil
19.4. Canada
19.5. Mexico
19.6. United States
20. Asia-Pacific Bird Flu Treatment Market
20.1. Introduction
20.2. Australia
20.3. China
20.4. India
20.5. Indonesia
20.6. Japan
20.7. Malaysia
20.8. Philippines
20.9. Singapore
20.10. South Korea
20.11. Taiwan
20.12. Thailand
20.13. Vietnam
21. Europe, Middle East & Africa Bird Flu Treatment Market
21.1. Introduction
21.2. Denmark
21.3. Egypt
21.4. Finland
21.5. France
21.6. Germany
21.7. Israel
21.8. Italy
21.9. Netherlands
21.10. Nigeria
21.11. Norway
21.12. Poland
21.13. Qatar
21.14. Russia
21.15. Saudi Arabia
21.16. South Africa
21.17. Spain
21.18. Sweden
21.19. Switzerland
21.20. Turkey
21.21. United Arab Emirates
21.22. United Kingdom
22. Competitive Landscape
22.1. Market Share Analysis, 2024
22.2. FPNV Positioning Matrix, 2024
22.3. Competitive Analysis
22.3.1. Alltech, Inc.
22.3.2. BioCryst Pharmaceuticals, Inc.
22.3.3. Boehringer Ingelheim International GmbH
22.3.4. Ceva Santé Animale
22.3.5. Cipla Limited
22.3.6. CSL Limited
22.3.7. F. Hoffmann-La Roche Ltd.
22.3.8. FATRO S.p.A.
22.3.9. Gilead Sciences, Inc.
22.3.10. GlaxoSmithKline PLC
22.3.11. Hester Biosciences Limited
22.3.12. Johnson & Johnson Services, Inc.
22.3.13. Macleods Pharmaceuticals Ltd
22.3.14. Merck KGaA
22.3.15. Moderna, Inc.
22.3.16. Novartis AG
22.3.17. PetSmart LLC
22.3.18. Pfizer Inc.
22.3.19. Sanofi S.A.
22.3.20. Serum Institute of India Pvt. Ltd.
22.3.21. Sinovac Biotech Ltd.
22.3.22. Takeda Pharmaceutical Company Limited
22.3.23. Tianjin Ringpu Biotechnology Co. Ltd.
22.3.24. Yebio Bioengineering Co. Ltd.
22.3.25. Zoetis Inc.
23. ResearchAI
24. ResearchStatistics
25. ResearchContacts
26. ResearchArticles
27. Appendix
List of Figures
FIGURE 1. BIRD FLU TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. BIRD FLU TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. BIRD FLU TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2024 VS 2030 (%)
FIGURE 24. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2024 VS 2030 (%)
FIGURE 26. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2024 VS 2030 (%)
FIGURE 28. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 32. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 36. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 37. BIRD FLU TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 38. BIRD FLU TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIRD FLU TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY H5N1, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY H5N6, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY H5N8, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY H7N9, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY H9N2, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADAMANTANES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY FAVIPIRAVIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CONVALESCENT PLASMA THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HYDRATION SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TRADITIONAL AND HERBAL REMEDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PROTEIN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VECTOR-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PREGNANT WOMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MILD CASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MODERATE CASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SEVERE CASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PUBLIC HEALTH CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INHALATIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GLOVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY MASKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PUBLIC HEALTH INITIATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINATION PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADVANCED ANTIVIRAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NEW VACCINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY NOVEL DRUG FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY VACCINE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HEALTHCARE COSTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PUBLIC AWARENESS CAMPAIGNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 130. CANADA BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 131. CANADA BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. CANADA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 133. CANADA BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 134. CANADA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 135. CANADA BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 136. CANADA BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 137. CANADA BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 138. CANADA BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 139. CANADA BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 140. CANADA BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 141. CANADA BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. CANADA BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 143. CANADA BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 144. CANADA BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 145. CANADA BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 146. CANADA BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 147. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 148. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 149. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 150. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 151. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 152. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 153. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 154. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 155. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 156. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 157. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 158. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 160. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 161. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 162. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 201. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 202. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 217. CHINA BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 218. CHINA BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 219. CHINA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 220. CHINA BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 221. CHINA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 222. CHINA BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 223. CHINA BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 224. CHINA BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 225. CHINA BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 226. CHINA BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 227. CHINA BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 228. CHINA BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. CHINA BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 230. CHINA BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 231. CHINA BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 232. CHINA BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 233. CHINA BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 234. INDIA BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 235. INDIA BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 236. INDIA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 237. INDIA BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 238. INDIA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 239. INDIA BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 240. INDIA BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 241. INDIA BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 242. INDIA BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 243. INDIA BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 244. INDIA BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 245. INDIA BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. INDIA BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 247. INDIA BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 248. INDIA BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 249. INDIA BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 250. INDIA BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 251. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 252. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 253. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 254. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 255. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 256. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 257. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 258. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 259. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 268. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 269. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 270. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 271. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 272. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 273. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 274. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 275. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 276. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 277. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 278. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 279. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 281. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 282. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 283. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 284. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 285. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 286. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 287. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 288. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 289. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 290. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 291. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 292. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 293. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 294. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 302. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 303. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 304. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 305. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 306. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 307. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 308. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 309. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 310. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 311. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 312. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 313. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 314. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 315. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 316. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY R&D AND INNOVATION, 2018-2030 (USD MILLION)
TABLE 317. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY INDUSTRY STAKEHOLDERS, 2018-2030 (USD MILLION)
TABLE 318. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY SOCIO-ECONOMIC IMPACT, 2018-2030 (USD MILLION)
TABLE 319. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY VIRUS STRAINS, 2018-2030 (USD MILLION)
TABLE 320. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 321. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUGS, 2018-2030 (USD MILLION)
TABLE 322. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY IMMUNOMODULATORS, 2018-2030 (USD MILLION)
TABLE 323. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2030 (USD MILLION)
TABLE 324. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 325. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 326. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 327. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 328. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 329. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 330. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 331. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY PREVENTIVE MEASURES, 2018-2030 (USD MILLION)
TABLE 332. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY PERSONAL PROTECT

Companies Mentioned

  • Alltech, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Cipla Limited
  • CSL Limited
  • F. Hoffmann-La Roche Ltd.
  • FATRO S.p.A.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Hester Biosciences Limited
  • Johnson & Johnson Services, Inc.
  • Macleods Pharmaceuticals Ltd
  • Merck KGaA
  • Moderna, Inc.
  • Novartis AG
  • PetSmart LLC
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Tianjin Ringpu Biotechnology Co. Ltd.
  • Yebio Bioengineering Co. Ltd.
  • Zoetis Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

H3N2 Infection - Pipeline Insight, 2025 - Product Image

H3N2 Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • 80 Pages
  • Global
From
Influenza A Infections - Pipeline Insight, 2025 - Product Image

Influenza A Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • 50 Pages
  • Global
From
Influenza Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Influenza Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Japan Influenza Medications Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

Japan Influenza Medications Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 80 Pages
  • Japan
From
Influenza Medication - Global Strategic Business Report - Product Image

Influenza Medication - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From

About the Avian Influenza Drug Market

The Avian Influenza Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat avian influenza, a type of influenza virus that primarily affects birds, but can also infect humans. These drugs are used to reduce the severity of symptoms and prevent further spread of the virus. They are typically administered in the form of antiviral medications, such as oseltamivir and zanamivir. Vaccines are also available to help protect against avian influenza. The Avian Influenza Drug market is highly competitive, with many companies offering products to treat the virus. Some of the major players in the market include GlaxoSmithKline, Sanofi, Novartis, Merck, and Pfizer. Other companies, such as Cipla, Mylan, and Sun Pharmaceuticals, also offer products for the treatment of avian influenza. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.